Stock BJDX BLUEJAY DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Bluejay Diagnostics, Inc.

Equities

BJDX

US0956333019

Market Closed - Nasdaq
Other stock markets
 21:30:00 22/05/2024 BST 		5-day change 1st Jan Change
0.4954 USD -2.96% Intraday chart for Bluejay Diagnostics, Inc. -5.64% -59.39%
04-02 Bluejay Diagnostics, Inc. Appoints Neil Dey as Principal Financial and Accounting Officer CI
03-28 Bluejay Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bluejay Diagnostics, Inc. Appoints Neil Dey as Principal Financial and Accounting Officer
Bluejay Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Top Premarket Decliners
Top Midday Decliners
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients
Bluejay Diagnostics Starts Clinical Study of Symphony IL-6 Test in Sepsis Patients; Shares Fall
Bluejay Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Sector Update: Health Care Stocks Climbing Late Afternoon
Sector Update: Health Care Stocks Higher in Afternoon Trading
Bluejay Diagnostics to Raise $1.6 Million in Registered Direct Offering
Bluejay Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Bluejay Diagnostics, Inc. Updates Symphony IL-6 Regulatory Strategy
Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Sector Update: Health Care Stocks Lifted with Broader Markets
Top Midday Decliners
Sector Update: Health Care Stocks Still Struggling for Firm Direction Tuesday Afternoon
Top Premarket Decliners
Bluejay Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt
Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America
Bluejay Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BJDX Stock
  4. News Bluejay Diagnostics, Inc.
  5. Other languages